Does shorter rehabilitation limit potential recovery poststroke?

Neurorehabilitation and Neural Repair
Susan E FasoliBruce T Volpe

Abstract

To examine retrospectively the recovery of patients engaged in robotic research during a 6 to 7-week course of inpatient rehabilitation. Because timing of the Interim evaluation at 3 1/2 weeks was comparable to the present length of inpatient stroke rehabilitation, the authors assessed whether significant gains in motor abilities occurred after the time when most stroke patients today are discharged home. Fifty-six inpatients with a single, unilateral stroke were randomly assigned to a robot therapy or robot exposure group. Therapists blinded to group assignment administered the Fugl-Meyer, Motor Status Score, and MRC motor power test. Significant improvements in upper-limb motor abilities occurred throughout a period approximately twice the present length of stay in inpatient rehabilitation. However, in the latter half of this period, patients who received conventional therapy showed little improvement, whereas patients who received robot training plus conventional therapy continued to improve. Further opportunities for recovery after stroke are possible by extending intensive therapy beyond present inpatient rehabilitation stays.

References

Aug 1, 1992·Stroke; a Journal of Cerebral Circulation·P W DuncanJ Feussner
May 1, 1995·Archives of Physical Medicine and Rehabilitation·H S JørgensenT S Olsen
Apr 16, 1998·IEEE Transactions on Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society·H I KrebsB T Volpe
Sep 30, 1999·Disability and Rehabilitation·J G BroeksA J Prevo
Jun 16, 2000·Age and Ageing·J M GregsonC L Watkins
Nov 28, 2001·Current Opinion in Neurology·B T VolpeN Hogan
Sep 18, 2002·Neurorehabilitation and Neural Repair·Mark FerraroBruce T Volpe
Nov 8, 2002·Archives of Physical Medicine and Rehabilitation·Henk T HendricksMachiel J Zwarts
Apr 12, 2003·Archives of Physical Medicine and Rehabilitation·Susan E FasoliNeville Hogan
Jul 9, 2004·Archives of Physical Medicine and Rehabilitation·Susan E FasoliNeville Hogan

❮ Previous
Next ❯

Citations

Oct 27, 2005·Experimental Brain Research·James L PattonFerdinando A Mussa-Ivaldi
Sep 19, 2007·Neurorehabilitation and Neural Repair·Gert KwakkelHermano I Krebs
Jul 12, 2014·Journal of Neuroengineering and Rehabilitation·Angelo BasterisFarshid Amirabdollahian
Oct 23, 2010·Disability and Rehabilitation·Kathryn HaywardSandra Brauer
Apr 22, 2008·Developmental Medicine and Child Neurology·Sophie CalvertPeta Mary Sharples
Sep 27, 2007·IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society·Hermano Igo KrebsNeville Hogan
Dec 14, 2004·Topics in Stroke Rehabilitation·Susan E FasoliNeville Hogan
Jan 8, 2014·Journal of Stroke·Won Hyuk Chang, Yun-Hee Kim
Mar 23, 2012·Topics in Stroke Rehabilitation·Eric Wade, Carolee J Winstein
Sep 7, 2016·Neurorehabilitation and Neural Repair·Janne M VeerbeekGert Kwakkel
Jul 13, 2018·PloS One·Fernanda Márcia Rodrigues Martins FerreiraClaysson Bruno Santos Vimieiro
Sep 4, 2010·Stroke; a Journal of Cerebral Circulation·Elaine L MillerUNKNOWN American Heart Association Council on Cardiovascular Nursing and the Stroke Council
Jun 2, 2009·Journal of Applied Biomechanics·Margaret A FinleyChristopher T Bever
Jun 29, 2006·Aging Clinical and Experimental Research·Stefano MasieroMarco Ortolani
Jul 23, 2020·Frontiers in Neurology·Echezona Nelson Dominic EkechukwuMayowa Ojo Owolabi
May 27, 2021·Journal of Medical Engineering & Technology·Nicola MarottaAntonio Ammendolia
Oct 26, 2021·The Cochrane Database of Systematic Reviews·Beth ClarkJane Burridge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.